The Food and Drug Administration is preparing to allow approximately 10 million doses of Johnson & Johnson’s Covid-19 vaccine manufactured at its Baltimore plant to be used in an accidentally contaminated company batch. The March vaccine, according to two people familiar with the matter.
Conclusion: These doses may be shipped abroad as part of the Biden administration’s plan to donate vaccines to countries in need. Demand for vaccination in the United States is slowing, and many states have stated that Johnson & Johnson shots are surplus.
Background: The FDA is reviewing the remaining vaccine doses made at the factory for safe use. This includes J & J Shot and 60 million doses of AstraZeneca’s Covid-19 vaccine.
FDA preparing to clear 10 million J & J vaccine doses at problematic factories
Source link FDA preparing to clear 10 million J & J vaccine doses at problematic factories